In sustained remission: After full criteria for sedative, hypnotic, or anxiolytic use dis— order were previously met, none of the criteria for sedative, hypnotic, or anxiolytic use disorder have been met at any time during a period of 12 months or longer (with the exception that Criterion A4. “Craving. or a strong desire or urge to use the sedative, hypnotic, or anxiolytic,” may be met).
Specify if:
In a controlled environment: This additional specifier is used it the individual is in an environment where access to sedatives, hypnotics, or anxiolytics is restricted.
Coding based on current severity: Note for |CD-10-CM codes: If a sedative, hypnotic. or anxiolytic intoxication; sedative, hypnotic, or anxiolytic withdrawal; or another sedative-, hypnotic-, or anxiolytic-induced mental disorder is also present, do not use the codes be- low for sedative, hypnotic, or anxiolytic use disorder. Instead the comorbid sedative, hyp- notic, or anxiolytic use disorder is indicated in the 4th character of the sedative, hypnotic-, or anxiolytic-induced disorder (see the coding note for sedative, hypnotic, or anxiolytic in- toxication; sedative, hypnotic, or anxiolytic withdrawal; or specific sedative-, hypnotic-, or anxiolytic-induced mental disorder). For example, if there is comorbid sedative-, hypnotic-, or anxiolytic-induced depressive disorder and sedative, hypnotic, or anxiolytic use disor- der, only the sedative-, hypnotic-, or anxiolytic-induced depressive disorder code is given with the 4th character indicating whether the comorbid sedative, hypnotic, or anxiolytic use disorder is mild, moderate, or severe: F13.14 for mild sedative, hypnotic, or anxiolytic use disorder with sedative-, hypnotic-, or anxiolytic-induced depressive disorder or F13.24 for a moderate or severe sedative, hypnotic, or anxiolytic use disorder with sedative-, hypnotic-, or anxiolytic-induced depressive disorder.
Specify current severity: 305.40 (F13.10) Mild: Presence of 2-3 symptoms.
304.10 (F13.20) Moderate: Presence of 4—5 symptoms.
304.10 (F13.20) Severe: Presence of 6 or more symptoms.
"In a controlled environment” applies as a further specifier of remission if the individual is both in remission and in a controlled environment (i.e., in early remission in a controlled environment or in sustained remission in a controlled environment). Examples of these environments are closely supervised and substance-free jails, therapeutic communities, and locked hospital units.
Sedative, hypnotic, or anxiolytic substances include benzodiazepines, benzodiazepine- like drugs (e.g., zolpidem, zaleplon), carbamates (e.g., glutethimide, meprobamate), barbiturates (e.g., secobarbital), and barbiturate-like hypnotics (e.g., glutethimide, meth- aqualone). This class of substances includes all prescription sleeping medications and almost all prescription antianxiety medications. Nonbenzodiazepine antianxiety agents (e.g., buspirone, gepirone) are not included in this class because they do not appear to be associated with significant misuse.